Bellevue Group AG - CRISPR THERAPEUTICS AG ownership

CRISPR THERAPEUTICS AG's ticker is CRSP and the CUSIP is H17182108. A total of 471 filers reported holding CRISPR THERAPEUTICS AG in Q3 2021. The put-call ratio across all filers is 1.71 and the average weighting 0.2%.

Quarter-by-quarter ownership
Bellevue Group AG ownership history of CRISPR THERAPEUTICS AG
ValueSharesWeighting
Q3 2023$40,778,376
-19.2%
898,400
-0.1%
0.66%
-8.8%
Q2 2023$50,486,702
+24.1%
899,300
-0.1%
0.72%
+21.8%
Q1 2023$40,697,954
+9.8%
899,800
-1.3%
0.59%
+20.1%
Q4 2022$37,060,808
-38.9%
911,705
-1.8%
0.49%
-43.5%
Q3 2022$60,664,000
+8.3%
928,305
+0.7%
0.87%
+10.0%
Q2 2022$56,031,000
-3.7%
922,005
-0.5%
0.79%
+17.2%
Q1 2022$58,182,000
-21.2%
926,905
-4.9%
0.68%
-11.2%
Q4 2021$73,861,000
-32.3%
974,6840.0%0.76%
-31.3%
Q3 2021$109,096,000
-30.3%
974,684
+0.8%
1.11%
-27.6%
Q2 2021$156,529,000
+31.3%
966,884
-1.2%
1.53%
+21.2%
Q1 2021$119,216,000
-14.4%
978,384
+7.6%
1.26%
-20.9%
Q4 2020$139,281,000
+75.4%
909,684
-4.2%
1.60%
+45.4%
Q3 2020$79,396,000
+35.0%
949,262
+18.6%
1.10%
+31.7%
Q2 2020$58,826,000
+73.3%
800,4620.0%0.83%
+26.6%
Q1 2020$33,948,000
-23.7%
800,462
+9.6%
0.66%
-6.7%
Q4 2019$44,489,000
+29.6%
730,462
-12.7%
0.70%
+10.5%
Q3 2019$34,315,000
-10.1%
837,162
+3.3%
0.64%
-2.1%
Q2 2019$38,173,000810,4620.65%
Other shareholders
CRISPR THERAPEUTICS AG shareholders Q3 2021
NameSharesValueWeighting ↓
Versant Venture Management, LLC 498,558$31,294,00031.24%
NEA Management Company, LLC 1,590,002$365,593,00010.56%
Ariose Capital Management Ltd 37,900$2,379,0009.30%
ARK Investment Management 9,404,071$590,294,0002.46%
NIA IMPACT ADVISORS, LLC 80,082$5,027,0002.44%
Nikko Asset Management Americas, Inc. 4,619,747$291,044,0002.14%
PLUSTICK MANAGEMENT LLC 50,000$3,139,0001.98%
Integral Health Asset Management, LLC 120,000$7,532,0001.96%
Valiant Capital Management, L.P. 240,683$15,108,0001.73%
Deuterium Capital Management, LLC 18,000$1,130,0001.45%
View complete list of CRISPR THERAPEUTICS AG shareholders